{"id":"23d127a6-8ca9-4c5f-bf84-4da41afeed74","modelId":"cd51c658-641a-4d09-b0ac-57aaf6874f42","versionId":null,"locationId":"ad195cdf-5dd4-49db-9d43-bef823cc4fc4","operatorId":"02ead9de-6bce-472d-9e76-d9c954d8d603","ownerId":null,"slug":"liberty-endovascular-tampa-florida-usa","status":"operational","firstSeen":"2026-03-02T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["surgical_assistance"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"medium_11_100","siteEnvironment":"indoor","operatorType":null,"sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.robotics247.com/article/tampa-general-hospital-adopts-liberty-endovascular-robotic-system","label":"Tampa General Hospital adopts LIBERTY endovascular robotic system","title":"Tampa General Hospital adopts LIBERTY endovascular robotic system","mediaType":"article","sourceName":"Robotics 24/7","publishedAt":"2026-03-02"}],"notes":"Tampa General Hospital — first health system in Florida to adopt the LIBERTY system. Affiliated with University of South Florida Morsani College of Medicine.","keyFacts":[],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-11T05:03:58.067Z","updatedAt":"2026-08-21T17:10:48.909Z","model":{"id":"cd51c658-641a-4d09-b0ac-57aaf6874f42","companyId":"02ead9de-6bce-472d-9e76-d9c954d8d603","modelName":"LIBERTY Endovascular Robotic System","slug":"liberty-endovascular","description":"Microbot Medical is a Hingham, MA-based commercial-stage medical device company (Nasdaq: MBOT) that developed the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The LIBERTY system received FDA 510(k) clearance in 2025.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"},{"url":"https://ir.microbotmedical.com/news-releases/news-release-details/microbot-medicalr-receives-fda-510k-clearance-its-libertyr","title":"Microbot Medical receives FDA 510(k) clearance for LIBERTY","sourceName":"Microbot Medical"},{"url":"https://ir.microbotmedical.com/news-releases/news-release-details/microbot-medicalr-commences-full-market-release-fmr-libertyr","date":"2026-04-01","title":"Microbot Medical commences full market release of LIBERTY","sourceName":"Microbot Medical"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"},{"label":"FDA 510(k) clearance","value":"Microbot Medical announced FDA 510(k) clearance for the LIBERTY Endovascular Robotic System (Microbot LIBERTY clearance)."},{"label":"Single-use remote operation","value":"Microbot Medical describes LIBERTY as a single-use, remotely operated endovascular robotic system intended to let physicians control navigation from a workstation (Microbot LIBERTY clearance)."},{"label":"Full market release","value":"Microbot Medical announced the full market release of LIBERTY in the United States in April 2026 (Microbot LIBERTY full market release)."}],"createdAt":"2026-07-02T21:26:26.322Z","updatedAt":"2026-10-09T21:56:27.507Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"02ead9de-6bce-472d-9e76-d9c954d8d603","name":"Microbot Medical","slug":"microbot-medical","description":"Microbot Medical Inc. (Nasdaq: MBOT) is a commercial-stage medical device company developing the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The company received FDA 510(k) clearance in September 2025 and commenced limited market release in November 2025, expanding to a full market release in Q2 2026. Headquartered in Hingham, Massachusetts with R&D operations in Yokneam, Israel.","status":"public","founded":2011,"hq":"Hingham, MA, USA","hqLat":42.2417669,"hqLng":-70.8897676,"hqGeocodedAt":"2026-08-05T00:51:16.415Z","hqAddress":null,"hqPrecision":null,"website":"microbotmedical.com","fundingTotal":"92200000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"MBOT","stockExchange":"NASDAQ","secCik":"0000883975","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-02T21:26:26.164Z","updatedAt":"2026-08-21T22:25:39.297Z"}},"version":null,"location":{"id":"ad195cdf-5dd4-49db-9d43-bef823cc4fc4","name":"Tampa","slug":"tampa-florida","kind":"city","parentLocationId":"8596e9c2-bb68-441e-a75b-c41f55ba9e83","region":"Florida","lat":27.9449854,"lng":-82.4583107,"reviewStatus":"reviewed","aliases":["Tampa, FL","Tampa, Florida, USA"],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-18T03:58:44.988Z","updatedAt":"2026-11-02T18:32:15.604Z"},"operator":{"id":"02ead9de-6bce-472d-9e76-d9c954d8d603","name":"Microbot Medical","slug":"microbot-medical","description":"Microbot Medical Inc. (Nasdaq: MBOT) is a commercial-stage medical device company developing the [LIBERTY Endovascular Robotic System](/models/liberty-endovascular-robotic-system), the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular procedures. The company received FDA 510(k) clearance in September 2025 and commenced limited market release in November 2025, expanding to a full market release in Q2 2026. Headquartered in Hingham, Massachusetts with R&D operations in Yokneam, Israel.","status":"public","founded":2011,"hq":"Hingham, MA, USA","hqLat":42.2417669,"hqLng":-70.8897676,"hqGeocodedAt":"2026-08-05T00:51:16.415Z","hqAddress":null,"hqPrecision":null,"website":"microbotmedical.com","fundingTotal":"92200000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://ir.microbotmedical.com/news-events/press-release","title":"Microbot Medical Wins Surgical Robotics Industry Award for the LIBERTY Endovascular Robotic System","sourceName":"GlobeNewswire"}],"keyFacts":[{"label":"FDA cleared","value":"LIBERTY Endovascular Robotic System; Nasdaq=MBOT"},{"label":"Stock","value":"Nasdaq: MBOT"},{"label":"Product","value":"LIBERTY Endovascular Robotic System"},{"label":"FDA clearance","value":"510(k) (2025)"},{"label":"Key feature","value":"Single-use, remotely operated"},{"label":"Ticker","value":"MBOT (Nasdaq)"},{"label":"Category","value":"Endovascular surgical robotics"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"MBOT","stockExchange":"NASDAQ","secCik":"0000883975","revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-02T21:26:26.164Z","updatedAt":"2026-08-21T22:25:39.297Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/liberty-endovascular-tampa-florida-usa","url":"https://registry.deploy.report/deployments/liberty-endovascular-tampa-florida-usa","name":"LIBERTY Endovascular Robotic System at Tampa","identifier":"23d127a6-8ca9-4c5f-bf84-4da41afeed74","startDate":"2026-03-02T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/tampa-florida","name":"Tampa"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/microbot-medical","name":"Microbot Medical"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/liberty-endovascular","name":"LIBERTY Endovascular Robotic System"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":["secondary-trade-publication"]}}}